Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.15.1 extracted from

  • Tiryaki, O.; Usalan, C.; Buyukhatipoglu, H.
    Effect of combined angiotensin-converting enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patients (2010), Nephrology, 15, 211-215.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
fosinopril causes a significant decrease in plasminogen activator inhibitor 1, PAI-1, levels, probably by aldosterone escape Homo sapiens

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
angiotensin I + H2O Homo sapiens
-
angiotensin II + His-Leu
-
?

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
angiotensin I + H2O
-
Homo sapiens angiotensin II + His-Leu
-
?

Synonyms

Synonyms Comment Organism
ACE
-
Homo sapiens
angiotensin-converting enzyme
-
Homo sapiens

General Information

General Information Comment Organism
physiological function ACE is responsible for degradation of bradykinin which is the most potent stimulus for tissue plasminogen activator secretion. The reaction product from angiotensin I cleavage, angiotensin II, has an important role on fibrinolytic balance causing release of plasminogen activator inhibitor 1 and consequently inhibits fibrinolysis Homo sapiens